Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
ElectroCore
4203
ElectroCore
Health Care
Medical
Medical Devices
Therapeutics
Developing therapies that directly, and non-invasively, target nerve signal imbalances to restore normal neurological function.
Suggest edits
Type
B2b
Founded
2005
Raised
$85.5M
Follow us
Companies in the same industry
Invenshure
NeuraLace Medical, Inc.
Theranica
Precision Ocular
Solace Therapeutics
Vivera Pharmaceuticals
Neuro Device Group
The Eye Machine
Beijing Allcure Medical Technology
Freespira, Inc.
Alexa global traffic share
Twitter followers
Overview
Funding
3
Add info
Latest funding
Show all
$34,000,000
Venture capital (Series B) - 2017
Merck Global Health Innovation Fund
Core Ventures Group
Knoll Capital Management
+2
$1,500,000
Debt financing - 2016
Team Size
10+
Employees
I work here
Location
United States
Headquarters
Explore United States
PE HUB
U.S. medical device firm electroCore IPO price set at $15 per share: Reuters
Health
